Optiscan Imaging Limited engages in the development and commercialization of confocal endomicroscopic imaging technologies for medical, translational, and pre-clinical applications in Australia, North America, Europe, and Asia. It offers ViewnVivo, a miniaturized fluorescence endomicroscope platform that brings imaging flexibility to preclinical research. The company also provides FIVE2 ViewnVivo system that enables virtual biopsies in living tissue. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.